Page 17 - Ioscience News Today

On Aug. 8, Congressman Greg Stanton (Arizona District 9) and Maricopa County Community College District (MCCCD) leaders gathered at the Center for Entrepreneurial Innovation (CEI) LabForce to announce the $1

Source BioScience, a provider of laboratory services, said it is launching a genomic sequencing service in San Diego. Source BioScience---which currently provides genomic services in the UK and Ire

"Im committed to building an economy of the future with these global partners who are helping propel Indiana forward by creating tomorrow’s businesses, today," said Gov. Eric Holcomb.

Vancouver, British Columbia--(Newsfile Corp. - August 19, 2022) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQB: EMHTF) ("Emerald" or the "Company") reports that its shareholders voted in favour

Dublin, Aug. 11, 2022 (GLOBE NEWSWIRE) -- The "Global Engineered T Cells Market (2022-2027) by Type, Application, End User, Geography, Competitive...

Third Party Analysis for Biotech and Pharma IndustriesKELOWNA, BC / ACCESSWIRE / August 11, 2022 / Lexaria Bioscience Corp. (Nasdaq:LEXX) (Nasdaq:LEXXW) (the "Company" or "Lexaria"), a global innovator

DJ Arix Bioscience plc Announces Changes to Board of Directors Arix Bioscience PLC (ARIX) Arix Bioscience plc Announces Changes to Board of Directors 10-Aug-2022 / 07:01 GMT/BST Dissemination of

Significant Milestone Achieved in Commercial Product Development ProgramAbbreviated 505(b)(2) Strategy Confirmed as an Appropriate NDA PathwayKELOWNA, BC / ACCESSWIRE / August 10, 2022 / Lexaria Bioscience

DJ Portfolio Company Disc Medicine Enters Definitive Merger Agreement with Gemini Therapeutics Arix Bioscience PLC (ARIX) Portfolio Company Disc Medicine Enters Definitive Merger Agreement with Gemini

DJ Artios initiates Phase 2 study of Pol? Inhibitor ART4215 in Combination with PARP Inhibitor Talazoparib in BRCA Deficient Breast Cancer Arix Bioscience PLC (ARIX) Artios initiates Phase 2 study